T

Thor Medical
TRMED

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
NOK1.54B
EV
NOK1.32B
Shares Outstanding
354.14M
Beta
-0.22
Industry
Biotechnology

Wall Street View

Analyst Rating
SELL
Analyst Target Price
Number of Analysts
1
P/E E
-
P/Revenue E
-

Historical 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Forecasted 3Y Growth Rate

Revenue
-
EPS
-
Operating Cash Flow
-
Free Cash Flow
-

Margins & Returns

Gross Margin E
-
Net Profit Margin E
-
ROE E
-
ROCE
-

Dividends

DPS E
-
Payout Ratio E
-
Div. Yield E
-
DPS Last 3Y CAGR
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Thor Medical ASA

gainify

T

Thor Medical ASA

TRMED

Thor Medical ASA produces and supplies alpha-particle emitters for cancer therapy in Norway. It develops Ra224, an isotope of radium; Pb-212, a radioactive isotope of lead; and Th-228, a radioactive isotope of thorium. The company was incorporated in 2009 and is headq...

Sector

Healthcare

Industry

Biotechnology

CEO

Kurth, Jasper

Employees

13

IPO Date

2015-03-23

Headquarters

Drammensveien 167, Oslo, Oslo, 0277, Norway

📊 Stock Price & Performance

The last closing price of Thor Medical (TRMED) is NOK4.89, reflecting a +6.54% change from the prior session. Last updated: April 1, 2026 at 8:20 AM Eastern Time

Review of Recent TRMED Stock Performance trends:Past 1 Month: Thor Medical (TRMED) shares changed by -10.71%.Past 3 Months: The stock recorded a change of +0.71%.Past 6 Months: TRMED shares posted a change of +18.06%. Last updated: March 7, 2026 at 8:43 PM Eastern Time

Over the last year, Thor Medical (TRMED) has established a 52-week price range between a high of NOK5.49 and a low of NOK1.80. This metric is essential for assessing the stock's annual volatility. Last updated: March 7, 2026 at 8:43 PM Eastern Time

Thor Medical (TRMED) is considered a low volatility stock. It has a beta of -0.22, which means it typically moves in the opposite direction of the broader market, with a magnitude of approximately 0.22 times the market's movement. Over the past 52 weeks, TRMED has traded within a NOK1.80 – NOK5.49 range. Last updated: March 7, 2026 at 8:43 PM Eastern Time

Based on current TRMED analyst forecasts, the consensus price target for Thor Medical (TRMED) is NOK3.50 for 2027. Relative to the current price of NOK4.89, this implies a potential downside of -17.65%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: April 1, 2026 at 8:20 AM Eastern Time

A NOK1,000 investment in Thor Medical 5 years ago, when the stock was trading around NOK25.91, would be worth approximately NOK188.70 today, based solely on share price performance (excluding dividends). This represents a total return of -81.13% over the period, equivalent to a compound annual growth rate (CAGR) of -28.36%. Past performance reflects historical price movements only and does not imply future results. Last updated: March 7, 2026 at 8:43 PM Eastern Time

💰 Financial Metrics & Reports

The current Thor Medical (TRMED) market capitalization is approximately NOK1.54B, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Thor Medical's market cap fluctuates with changes in its share price and share count. Last updated: March 7, 2026 at 8:43 PM Eastern Time

📅 Earnings & Dividends

Thor Medical (TRMED) does not currently pay a dividend. Over the last twelve months (LTM), the company paid NOK0.00 per share in dividends, and no dividend payments are currently expected over the next twelve months (NTM). Companies that do not pay dividends typically prioritize reinvesting cash into growth initiatives, capital expenditures, debt reduction, or strategic investments, though dividend policy may change in the future.

📈 Analyst Information

Analyst assessments of whether Thor Medical (TRMED) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: NOK4.89Consensus price target: NOK3.50Implied return: -17.65% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: April 1, 2026 at 8:20 AM Eastern Time

Based on the latest available analyst coverage, Thor Medical (TRMED) currently carries a Sell consensus rating. Analysts' average TRMED price target is NOK3.50. Relative to the current share price of NOK4.89, this suggests a potential price change of approximately -17.65%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: April 1, 2026 at 8:20 AM Eastern Time

Like other publicly traded stocks, Thor Medical (TRMED) shares are bought and sold on stock exchanges such as OB and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Thor Medical (TRMED) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add TRMED to your watchlist.

Thor Medical trades under the ticker symbol TRMED on the OB stock exchange. The ticker TRMED is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

As of the most recently reported period, Thor Medical (TRMED) employs approximately 13 people worldwide. Reported employee figures may fluctuate over time due to hiring activity, restructuring, automation initiatives, or changes in business strategy. Headcount data is typically disclosed in company filings and reflects full-time employees unless otherwise stated. Last updated: March 7, 2026 at 8:43 PM Eastern Time

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps
Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.
View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.
© 2026 Gainify. All rights reserved.